Finpedmed
teemakuva

FINPEDMED Strategy for 2018

 Mission

We promote the health of Finnish (European) children by increasing research, development, and registration of new medicines while trying to avoid any unnecessary trials in children. The goal is to obtain medicines and treatments that are safe and based on research evidence.

Values

Our operations are based on work performance that is reliable and responsible and of high-quality both ethically and scientifically. We are a non-profit organization managed by a juridical host organization (Helsinki University Hospital, Department of Children and Adolescents). Our operations are transparent and we exchange information openly both nationally and internationally. We cooperate with all pharmaceutical companies and Competent Authorities. We represent doctors engaged in scientific research and other experts in the field, and develop national harmonized practices, materials, and operating procedures promoting scientific research.

Vision

We want to become one the most effective pediatric medicines research networks in Europe and to build a new and internationally acknowledged Nordic network of experts (NordicPedMed).

Services

We provide expert services through our own closed member registry and through a new kind of an e-Service Request system. Our services to the pharma industry are subject to a charge implying that our experts are compensated for their tasks.  We are a member of the European Network of Paediatric Research (Enpr-EMA) coordinated by the European Medicines Agency (EMA). Our services are based on the requirements of the EU Paediatric Regulation (EU 1901/2006) and valid legislation.  To our own members we produce internal services supporting research and offer new research assignments.

Training and communication

We train our own experts and thus increase their special expertise. We also offer additional training to others. We aim at providing all parties with open information about our operations: authorities, patient organizations, physicians' specialist associations, pharmacies, and hospitals.  We actively participate in European, Nordic and international congresses and meetings and do our best to have our voices heard.

 Customer promise and service rationale

Through our nation-wide network we offer the most sophisticated, cutting edge expertise in the planning and performance of pediatric clinical trials. Our services cover all pediatric specialties in Finland (excluding vaccines). In addition, we offer expertise in the sub-sectors of pediatric clinical pharmacology, drug formulations suited for children, and in medical ethics. However, we do not act as a Competent Authority, do not make respective decisions, and we do not give ethical opinions. We serve clinical drugs trials received from the pharmaceutical industry as well as from investigators.

Our services are coordinated and supported in a centralized fashion by one operational unit (office). Our customers include international pharmaceutical companies, which operate in Finland, in the Nordic countries and Europe as well as European and national academic research groups. We also provide services to the Finnish and European Competent Authorities (medical, regulatory and ethical) and such institutions and organizations that need our expert services.

Funding and operations

During the current term, we aim at creating a new permanent funding scheme to replace the previous structure of granted support funds. We aim at increasing the number of our experts and service requests and developing new measures for our operations.

 

FINPEDMED Strategy for 2018

 Mission

We promote the health of Finnish (European) children by increasing research, development, and registration of new medicines while trying to avoid any unnecessary trials in children. The goal is to obtain medicines and treatments that are safe and based on research evidence.

Values

Our operations are based on work performance that is reliable and responsible and of high-quality both ethically and scientifically. We are a non-profit organization managed by a juridical host organization (Helsinki University Hospital, Department of Children and Adolescents). Our operations are transparent and we exchange information openly both nationally and internationally. We cooperate with all pharmaceutical companies and Competent Authorities. We represent doctors engaged in scientific research and other experts in the field, and develop national harmonized practices, materials, and operating procedures promoting scientific research.

Vision

We want to become one the most effective pediatric medicines research networks in Europe and to build a new and internationally acknowledged Nordic network of experts (NordicPedMed).

Services

We provide expert services through our own closed member registry and through a new kind of an e-Service Request system. Our services to the pharma industry are subject to a charge implying that our experts are compensated for their tasks.  We are a member of the European Network of Paediatric Research (Enpr-EMA) coordinated by the European Medicines Agency (EMA). Our services are based on the requirements of the EU Paediatric Regulation (EU 1901/2006) and valid legislation.  To our own members we produce internal services supporting research and offer new research assignments.

Training and communication

We train our own experts and thus increase their special expertise. We also offer additional training to others. We aim at providing all parties with open information about our operations: authorities, patient organizations, physicians' specialist associations, pharmacies, and hospitals.  We actively participate in European, Nordic and international congresses and meetings and do our best to have our voices heard.

 Customer promise and service rationale

Through our nation-wide network we offer the most sophisticated, cutting edge expertise in the planning and performance of pediatric clinical trials. Our services cover all pediatric specialties in Finland (excluding vaccines). In addition, we offer expertise in the sub-sectors of pediatric clinical pharmacology, drug formulations suited for children, and in medical ethics. However, we do not act as a Competent Authority, do not make respective decisions, and we do not give ethical opinions. We serve clinical drugs trials received from the pharmaceutical industry as well as from investigators.

Our services are coordinated and supported in a centralized fashion by one operational unit (office). Our customers include international pharmaceutical companies, which operate in Finland, in the Nordic countries and Europe as well as European and national academic research groups. We also provide services to the Finnish and European Competent Authorities (medical, regulatory and ethical) and such institutions and organizations that need our expert services.

Funding and operations

During the current term, we aim at creating a new permanent funding scheme to replace the previous structure of granted support funds. We aim at increasing the number of our experts and service requests and developing new measures for our operations.